382 Jobs Found for Abata Therapeutics
About us: Abata is developing regulatory T cells (Tregs) therapies for autoimmunity to transform lives with cures for Multiple Sclerosis and Type 1 Diabetes. By arming Tregs with T cell receptors that provide tissue-specific activation at the site of disease, Tregs will restore homeostasis in the tissue enabling a robust, durable response, while a...
About us: Abata is developing regulatory T cells (Tregs) therapies for autoimmunity to transform lives with cures for Multiple Sclerosis and Type 1 Diabetes. By arming Tregs with T cell receptors that provide tissue-specific activation at the site of disease, Tregs will restore homeostasis in the tissue enabling a robust, durable response, while a...
ProFound Therapeutics, Inc. | Boston, MA ProFound Therapeutics: Machine Learning Engineer
NewPosted 05 Oct 2024Flagship PioneeringProFound Therapeutics: Machine Learning Engineer Boston, MA USA Company Summary: ProFound Therapeutics is discovering proteins hidden within the expanded human proteome to uncover novel drugs and drug targets, producing first-in-class medicines for a multitude of diseases. The company’s ProFoundry Platform uses state-of-the-art protein detection t...
Company Summary: ProFound Therapeutics is discovering proteins hidden within the expanded human proteome to uncover novel drugs and drug targets, producing first-in-class medicines for a multitude of diseases. The company’s ProFoundry Platform uses state-of-the-art protein detection technologies to systematically identify and validate proteins an...
Senior Machine Learning Engineer - Oligonucleotide Therapeutics - US
NewPosted 01 Oct 2024GlaxoSmithKlineSite Name: USA - California - San FranciscoPosted Date: Aug 28 2024At GSK we see a world in which advanced applications of Machine Learning and AI will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side ef...
Senior Machine Learning Engineer – Oligonucleotide Therapeutics – US
NewPosted 29 Sep 2024GlaxoSmithKlineSite Name: USA - California - San Francisco Posted Date: Aug 29 2024 At GSK, we see a world in which advanced applications of Machine Learning and AI will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side...
Senior Machine Learning Engineer – Oligonucleotide Therapeutics – US
NewPosted 06 Oct 2024GlaxoSmithKlineSite Name: USA - California - San FranciscoPosted Date: Aug 29 2024At GSK, we see a world in which advanced applications of Machine Learning and AI will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side e...
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation...
Senior Machine Learning Engineer – Oligonucleotide Therapeutics – US
NewPosted 05 Oct 2024GlaxoSmithKlineSite Name: USA - California - San FranciscoPosted Date: Aug 29 2024At GSK, we see a world in which advanced applications of Machine Learning and AI will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side e...
Senior Machine Learning Engineer – Oligonucleotide Therapeutics – US
NewPosted 06 Oct 2024GlaxoSmithKlineSite Name: USA - California - San FranciscoPosted Date: Aug 29 2024At GSK, we see a world in which advanced applications of Machine Learning and AI will allow us to develop novel therapies to existing diseases and to quickly respond to emerging or changing diseases with personalized drugs, driving better outcomes at reduced cost with fewer side e...